Five-year maintenance of clinical response and improvements in health-related quality of life in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2.

In Dermatology
by ClinOwl

Psoriasis is a chronic disease requiring long-term therapy.Physician- and patient-reported outcomes (PROs) were evaluated through week 252 in VOYAGE 1 and VOYAGE 2.A total of 1829 patients were randomized at […]